Equity |
6 Months Ended |
|---|---|
Jun. 30, 2025 | |
| Stockholders' Equity Note [Abstract] | |
| Equity | Note 5 - Equity
Common Stock
The Company has 75,000,000, $0.0001 par value shares of voting common stock authorized.
During the six months ended June 30, 2025, there were no issuances of common stock.
During the six months ended June 30, 2024, the Company issued 700,000 shares of common stock for cash proceeds of $175,000.
As of June 30, 2025 and December 31, 2024, the Company had 43,916,221 shares of common stock issued and outstanding.
Preferred Stock
On October 19, 2021, the Company filed a Certificate of Amendment to its Articles of Incorporation authorizing up to 5,000,000 shares of Preferred Stock, par value $0.0001 per share, with such rights, preferences and limitations as may be set forth in resolutions adopted by the Board of Directors. On November 1, 2021, the Company filed a Certificate of Designation designating 1,000,000 shares of Preferred Stock as Series A Convertible Preferred Stock (the “Series A”). Each share of the Series A is convertible into three shares of the Company’s common stock at the holder’s election, subject to a 4.99% beneficial ownership limitation which may be increased to 9.99% upon 61 days’ notice.
During the six months ended June 30, 2025 and 2024 there were no issuances of preferred stock. As of June 30, 2025 and December 31, 2024, the Company had 140,000 shares of Series A Convertible Preferred Stock outstanding. |